PharmaCyte Biotech (PMCB) Stock Chart & Stock Price History → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free PMCB Stock Alerts $2.11 -0.01 (-0.47%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial Media PharmaCyte Biotech Stock Price Performance5 Day Performance-0.94%1 Month Performance-10.97%3 Month Performance-3.65%6 Month Performance+1.44%Year-To-Date Performance-2.31%1 Year Performance-27.74% Receive PMCB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy PMCB Stock Chart for Sunday, April, 28, 2024 PMCB Chart by TradingView PharmaCyte Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$2.12$2.11-0.47%$2.12$2.085,644 shs$17.83 million04/25/2024$2.18$2.12-2.75%$2.15$2.0814,464 shs$17.91 million04/24/2024$2.13$2.18+2.35%$2.20$2.1312,340 shs$18.42 million04/23/2024$2.15$2.13-0.93%$2.19$2.131,645 shs$18.00 million04/22/2024$2.12$2.15+1.42%$2.28$2.097,893 shs$18.17 million04/19/2024$2.20$2.12-3.64%$2.20$2.1110,632 shs$17.91 million Get the Latest News and Ratings for PMCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$2.12$2.20+3.77%$2.31$2.075,886 shs$18.59 million04/17/2024$2.15$2.12-1.40%$2.31$2.128,821 shs$17.91 million04/16/2024$2.11$2.15+1.90%$2.16$2.0712,303 shs$18.17 million04/15/2024$2.23$2.11-5.38%$2.39$2.1126,470 shs$17.83 million04/12/2024$2.30$2.23-3.04%$2.46$2.2338,004 shs$18.84 million04/11/2024$2.26$2.30+1.77%$2.40$2.2333,629 shs$19.44 million04/10/2024$2.30$2.26-1.74%$2.29$2.238,936 shs$19.10 million04/09/2024$2.39$2.30-3.77%$2.38$2.3019,663 shs$19.44 million04/08/2024$2.42$2.39-1.24%$2.45$2.3115,781 shs$20.20 million04/05/2024$2.52$2.42-3.97%$2.50$2.4212,120 shs$20.45 million04/04/2024$2.51$2.52+0.40%$2.55$2.4613,059 shs$21.29 million04/03/2024$2.48$2.51+1.21%$2.54$2.4529,029 shs$21.21 million04/02/2024$2.45$2.48+1.43%$2.50$2.4251,066 shs$20.96 million04/01/2024$2.37$2.45+3.16%$2.45$2.3620,009 shs$20.66 million03/29/2024$2.37$2.37$2.50$2.2934,542 shs$20.05 million03/28/2024$2.44$2.37-2.87%$2.50$2.2934,541 shs$20.05 million03/27/2024$2.44$2.44$2.58$2.3414,826 shs$20.64 million03/26/2024$2.48$2.44-1.61%$2.56$2.34345,489 shs$20.64 million03/25/2024$2.44$2.48+1.64%$2.54$2.4556,028 shs$20.98 million03/22/2024$2.41$2.44+1.24%$2.45$2.3438,144 shs$20.64 million03/21/2024$2.38$2.41+1.26%$2.50$2.3452,987 shs$20.39 million03/20/2024$2.14$2.38+11.21%$2.40$2.07114,086 shs$20.52 million03/19/2024$2.01$2.14+6.47%$2.20$1.96120,832 shs$18.45 million03/18/2024$1.95$2.01+3.08%$2.10$1.9429,992 shs$17.33 million03/15/2024$2.04$1.95-4.41%$2.09$1.9543,564 shs$16.81 million03/14/2024$1.98$2.04+3.03%$2.04$1.9728,844 shs$17.59 million03/13/2024$1.97$1.98+0.51%$2.02$1.9414,065 shs$17.07 million03/12/2024$2.01$1.97-1.99%$2.05$1.9710,877 shs$16.97 million03/11/2024$2.06$2.01-2.43%$2.06$2.0010,929 shs$17.33 million03/08/2024$2.05$2.06+0.49%$2.09$2.056,861 shs$17.76 million03/07/2024$2.03$2.05+0.99%$2.06$2.0210,925 shs$17.67 million03/06/2024$2.03$2.03$2.08$2.0119,373 shs$17.50 million03/05/2024$2.05$2.03-0.98%$2.09$2.027,142 shs$17.50 million03/04/2024$2.08$2.05-1.44%$2.10$2.0519,170 shs$17.67 millionForget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details03/01/2024$2.10$2.08-0.95%$2.13$2.075,703 shs$17.93 million02/29/2024$2.10$2.10$2.15$2.1022,825 shs$18.10 million02/28/2024$2.02$2.10+3.96%$2.15$2.0213,664 shs$18.10 million02/27/2024$2.08$2.02-2.88%$2.10$2.0022,016 shs$17.40 million02/26/2024$2.06$2.08+0.97%$2.18$2.0721,315 shs$17.93 million02/23/2024$2.06$2.06$2.10$2.0611,961 shs$17.76 million02/22/2024$2.06$2.06$2.10$2.065,986 shs$17.76 million02/21/2024$2.06$2.06$2.12$2.0314,503 shs$17.76 million02/20/2024$2.07$2.06-0.48%$2.10$2.0511,088 shs$17.76 million02/19/2024$2.07$2.07$2.13$2.074,600 shs$17.84 million02/16/2024$2.09$2.07-0.96%$2.13$2.074,689 shs$17.84 million02/15/2024$2.11$2.09-0.95%$2.11$2.069,468 shs$18.02 million02/14/2024$2.05$2.11+2.93%$2.11$2.037,326 shs$18.19 million02/13/2024$2.17$2.05-5.53%$2.17$2.0529,456 shs$17.67 million02/12/2024$2.24$2.17-3.13%$2.24$2.176,877 shs$18.71 million02/09/2024$2.17$2.24+3.23%$2.24$2.167,337 shs$19.31 million02/08/2024$2.18$2.17-0.46%$2.22$2.167,673 shs$18.70 million02/07/2024$2.17$2.18+0.46%$2.22$2.162,596 shs$18.79 million02/06/2024$2.17$2.17$2.22$2.179,331 shs$18.71 million02/05/2024$2.23$2.17-2.69%$2.23$2.1619,395 shs$18.71 million02/02/2024$2.22$2.23+0.68%$2.23$2.165,751 shs$19.22 million02/01/2024$2.19$2.22+1.14%$2.24$2.179,599 shs$19.09 million01/31/2024$2.25$2.19-2.67%$2.25$2.193,054 shs$18.88 million01/30/2024$2.24$2.25+0.45%$2.25$2.207,783 shs$19.40 million01/29/2024$2.19$2.24+2.28%$2.27$2.147,737 shs$19.30 million Related Companies: APTO Stock Chart AIM Stock Chart NSTGQ Stock Chart EVAX Stock Chart SNTI Stock Chart ZIVO Stock Chart COEP Stock Chart IKT Stock Chart BCDA Stock Chart PLUR Stock Chart Receive PMCB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PMCB) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHis win rate puts Warren Buffett to shame… Investing DailyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCyte Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.